KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2025)

Hims & Hers Health's Amortization of Deferred Charges history spans 3 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges changed N/A year-over-year to $1.7 million; the TTM value through Dec 2025 reached $3.5 million, changed N/A, while the annual FY2025 figure was $4.5 million, N/A changed from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $1.7 million at Hims & Hers Health, roughly flat from $1.7 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.7 million in Q3 2025 and bottomed at $144000.0 in Q1 2021.